Nextel Medical Sets $0.003 Price for 27.9M Remaining Reg A Shares
MAJI has more than doubled off its 52-week low of $0.002.
Summary
Nextel Medical fixed the price of its remaining Regulation A offering shares at $0.003, quantifying 27.9 million company shares and 329,431 selling shareholder shares still available. The offering is highly dilutive and the company remains in financial distress.
Key Events · Financing and Capital Events · MAJI
-
Offering Price Fixed at $0.003
The remaining 27,916,666 company shares and 329,431 selling shareholder shares are now offered at a fixed price of $0.003 per share, down from the previously disclosed range of $0.001-$0.01.
-
Minimal Proceeds Expected
If all remaining company shares are sold, gross proceeds would be only $83,750, with net proceeds of $68,750 after $15,000 in offering expenses. Selling shareholders would receive $989.
-
Severe Dilution and Negative Book Value
The company's net tangible book value was $(984,807) as of March 31, 2026, or $(0.02) per share. Purchasers at $0.003 face immediate dilution of $0.013 per share if 100% of remaining shares are sold.
-
Going Concern Warning
The filing reiterates substantial doubt about the company's ability to continue as a going concern, with cash of only $177 as of March 31, 2026 and a working capital deficit of approximately $726,256.
Analysis · MAJI · Technology
Nextel Medical has finalized the terms of its ongoing Regulation A offering, setting a fixed price of $0.003 per share for the 27.9 million remaining company shares and 329,431 remaining selling shareholder shares. This is a material update from the prior disclosure, which only indicated a price range of $0.001 to $0.01. The offering is highly dilutive at this price level, and the company's own financials show a going concern warning, negative net tangible book value, and a working capital deficit. The fixed price is below the last reported closing price of $0.0065 on September 3, 2026, meaning new purchasers are buying at a discount to the recent market, but the company receives only minimal proceeds — at most $83,750 from the remaining company shares — which is unlikely to fund its stated $12.75 million acquisition plans or its $300,000 IND trial goals.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MAJI was trading at $0.01 on OTC in the Technology sector, with a market capitalization of approximately $535.4K. The 52-week trading range was $0.00 to $0.21. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.